by Steven A. Grossman | Apr 17, 2025 | Short Takes and Updates
There is a document widely-circulated this morning that purports to be the OMB passback to HHS of the draft proposed FY 26 HHS President’s budget request. It includes proposed numbers for FDA funding for the coming fiscal year. It is still subject to negotiation...
by Steven A. Grossman | Apr 15, 2025 | Short Takes and Updates
While FDA’s responsibilities have not changed, its capacity to perform its duties has been significantly reduced. After subtracting approximately 4,500 employees[1] from the agency’s 19,000 employee workforce, it cannot possibly sustain its heavy...
by Steven A. Grossman | Apr 11, 2025 | Short Takes and Updates
Earlier this week, I posted an “FDA-Related Thought of the Day.” According to LinkedIn, it has generated an astounding 29,796 impressions (and counting!). That’s a lot more interest than it garnered when I first posted it a month ago (here). Here is what I said...
by Steven A. Grossman | Apr 7, 2025 | Short Takes and Updates
Last Thursday, Alec Gaffney of AgencyIQ declared “…the future of FDA’s user fee programs is in extreme jeopardy” (here). Alec has a well-deserved reputation as one of the best FDA analysts. Alec talks; people listen. For the most part, I agree with him and have...
by Steven A. Grossman | Apr 7, 2025 | Short Takes and Updates
January 24, 2025 column in FDA Matters: https://www.fdamatters.com/fdamatters/keep-calm-and-carry-on-lessons-from-trump-10 Eight years ago, just before President Trump was sworn in for the first time, I expressed my belief in FDA’s ability to survive change. I...